Advances in Medicine Cause New, Groundbreaking Drug by Quantum Genomics

Discussion in 'Other General Discussion' started by Matt D. Burditt, Aug 14, 2019.

  1. [​IMG]
    Advances in Medicine Cause New,
    Groundbreaking Drug by Quantum Genomics (QNNTF) to Help With Chronic Hypertension



    Quantum Genomics Corp.(QGC) is a global Biotechnology company maximizing the developments and discoveries of academic research into breakthrough treatments for human disease. Quantum Genomics Corp (GGC), has unique expertise in the detection and selection of highly promising life science technology projects. QGC (quantum genomics) co-develops products with academic teams. QGC's strategic alliances and business partnerships range from disease-oriented therapeutic collaborations, technology transfer-agreements, and marketing/licensing agreements in the fields of recombinant proteins, monoclonal antibodies, and advanced chemical compounds. Quantum Genomics Corp. develops public/private partnerships to speed up the process of translational research/development, to turn basic research into products.

    For more information please look here==> Firibastat
     

Share This Page